TECHNO CHEMICAL corp.

ポリサイエンス社製品
cat.#14706

Resiquimod
Resiquimod, an imidazoquinoline compound, is a TLR7/TLR8 synthetic agonist that can be used as a vaccine adjuvant to improve antigen-specific antibody production. Resiquimod is known to activate immune cells and upregulate the levels of cytokines like TNF-α, IL-6, IL-12, and IFN-α. SYNONYMS: R 848 >98% SOLUBILITY: DMSO, Ethanol APPEARANCE: Solid-Powder APPLICATION(S): Vaccines References Wilkinson, Alexander, et al. (2018). "Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+ CAF01." Journal of Controlled Release 291, 1-10.:

Cat.#	容量	定価
14706-10	10 mg	¥11,100
14706-50	50 mg	¥41,800

CAS	144875-48-9
M.W.：	314.38 g/mol
保管温度＆取扱：	-20℃
出荷温度：	ドライアイス出荷

製品のお見積りご依頼時は、「製品コード」と「数量」を必ず明記してください。 海外輸入製品につき、製品コードおよび数量がありませんとお見積りいたしかねます。